NIH-funded research NIH-funded research

New immune therapy to help recovery after brain injuries

Official title: Novel immune therapy to promote functional recovery after traumatic brain injury

Funded at Veterans Health Administration · NIH-10950305 · Data updated 2026-11-12

This study is exploring a new treatment that helps the immune system heal the brain after a traumatic injury, and it's looking for people with brain injuries to see if this therapy can help them recover better.

More Brain Injury research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startOctober 1, 2022
Project endSeptember 30, 2026
Funding year2025
NIH project number5I01BX005589-03
Project IDNIH-10950305 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are adults aged 21 and older who have experienced a traumatic brain injury.

Less likely to help

Patients with chronic neurological conditions unrelated to traumatic brain injury may not benefit from this research.

What this research studies

This research investigates a novel immune therapy aimed at enhancing recovery from traumatic brain injury (TBI). It focuses on understanding how specific immune cells, particularly regulatory T cells, can be activated to reduce inflammation and promote brain repair. By studying the interactions between these immune cells and the brain's response to injury, the research aims to identify new therapeutic targets that could lead to improved outcomes for individuals suffering from TBI. Patients may be involved in trials that assess the effectiveness of this therapy in promoting functional recovery.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and quality of life for patients with traumatic brain injuries.

How similar studies have gone: Previous studies have shown promise in using immune modulation for neuroprotection in stroke, suggesting potential for success in similar approaches for TBI.

Where this research is happening

  • Veterans Health Administration
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Hu, Xiaoming — Veterans Health Administration
  • Study coordinator: Hu, Xiaoming

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.